Open Access274. Legionella bozemanii (Fluoribacter bozemanae) Brain Abscess in a Renal Transplant Recipient
Author(s) -
Abrar Ahmad Khan,
Sreechandra L Kruthiventi,
Rahul Mahapatra,
Soma Sanyal,
Wesley D Kufel
Publication year - 2021
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofab466.476
Subject(s) - medicine , azithromycin , brain abscess , legionella , moxifloxacin , abscess , surgery , antibiotics , microbiology and biotechnology , genetics , bacteria , biology
Abstract Background Legionnaires’ disease is a potentially fatal multi-system disease caused by Legionella species. However, extra-pulmonary Legionella disease is rare and is typically associated with Legionella species other than L. pneumophila in immunocompromised patients.Methods We present a 55-year-old immunocompromised male with history of living-related renal transplant secondary to IgA nephropathy (day 0) which was complicated by T-cell mediated rejection requiring anti-thymocyte globulin and elotuzumab (day 130).Results Patient was hospitalized on day 184 with community-acquired pneumonia and treated with piperacillin-tazobactam and azithromycin. Three weeks later (day 214), he presented with new-onset seizures and was found to have a frontal brain abscess on MRI. His clinical course and brain imaging worsened despite undergoing multiple operative drainage procedures, placement of an extra ventricular drain, and receiving broad-spectrum antimicrobials. L. bozemanii was first identified from cerebrospinal fluid (CSF) on buffered charcoal yeast extract (BCYE) agar from day 240 and was also later confirmed by 16S rRNA sequencing. Susceptibilities were unavailable due to poor organism growth. Of note, his allergy history was significant for rash with ciprofloxacin and levofloxacin. Based on the low severity of the allergic reaction and need for central nervous system penetration, moxifloxacin 400 mg intravenously every 24 hours was initiated on day 244 in addition to broad-spectrum antibiotics. Subsequent CSF cultures were positive for L. bozemanii until the CSF culture on day 250. Due to poor clinical response, azithromycin and intrathecal polymyxin B were added for salvage therapy on day 255. His neurological status continued to worsen and he eventually succumbed to his illness on day 262. 08/31/20 MRI BrainNew solitary ring-enhancing lesion with significant surrounding vasogenic edema within the anterior right frontal lobe. 09/23/20 MRI BrainPost-Surgical right frontal lobe with edema, persistent cerebritis, and mass effect on the lateral ventricles. Fluoribacter BozemanaeFormerly known as Legionella bozemanii, an intracellular GNR grown on BCYE. Conclusion We present a diagnostically challenging case of L. bozemanii brain abscess in an immunocompromised patient. To our knowledge, this is the first case of culture proven L. bozemanii brain abscess in the literature. Considering the fastidious growth of the organism, fatal nature of the infection, and narrow therapeutic profile, Legionella infection should be considered in a multi-system disease in immunocompromised patients.Disclosures Wesley Kufel, PharmD , Melinta (Grant/Research Support) Merck (Grant/Research Support) Theratechnologies, Inc. (Advisor or Review Panel member)